Clinical trial Recruiting at 1 site Observational

International registry for Rapid-onset Obesity with Hypothalamic Dysfunction

Official title: International Rapid-onset Obesity With Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) REDCap Registry

Run by Ann & Robert H Lurie Children's Hospital of Chicago · NCT03135730 · Data updated 2026-11-12

This study is creating a global registry to gather health information from people with Rapid-onset Obesity with Hypothalamic Dysfunction (ROHHAD) to help doctors better understand and manage the condition.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorAnn & Robert H Lurie Children's Hospital of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJune 1, 2013
Main results expectedDecember 31, 2034
Study endsDecember 31, 2039
Registry record updatedSeptember 3, 2026
Trial IDNCT03135730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with a clinical diagnosis of suspected or confirmed ROHHAD.

Probably not a fit

Patients with clinical diagnoses that are not consistent with ROHHAD may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study establishes the first international registry for patients with Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD). It aims to collect detailed health information from ROHHAD patients and their physicians worldwide to better understand the disease's progression and associated health issues. By analyzing this data, the study seeks to improve early recognition of ROHHAD and provide guidelines for healthcare providers in managing these patients. The registry will utilize a secure data capture system to ensure patient confidentiality and data integrity.

Why it matters

Potential benefit: If successful, this registry could lead to improved diagnosis and management of ROHHAD, enhancing patient outcomes.

How similar studies have gone: While the approach of creating a registry for rare diseases is not novel, the specific focus on ROHHAD and its unique challenges presents an opportunity for new insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of suspected ROHHAD
* Clinical diagnosis of confirmed ROHHAD

Exclusion Criteria:

* Clinical diagnosis not consistent with ROHHAD

Where it's running

  • Ann & Robert H. Lurie Children's Hospital of Chicago and the Stanley Manne Children's Research Institute
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.